Astec LifeSciences filed a Reg 54 Nil Security Cover certificate for its listed unsecured NCDs, stating the security cover format is not applicable. This is routine compliance paperwork with no new money or business event.
Astec Lifesciences filed a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, for the quarter ended September 30, 2026, confirming no rematerialization requests received.
Astec LifeSciences confirmed nil deviation in the utilization of proceeds from its listed Non-Convertible Debentures for the quarter ended 30th June, 2026.